Literature DB >> 13141140

A study on the behaviour of leprosy in serological tests for syphilis.

R N NARULA, V P GUPTA.   

Abstract

Blood samples from 58 leprosy patients were tested by the MK1R and VDRL slide tests, the latter being performed on normally inactivated sera and on the same sera heated for 5 minutes at 65 degrees C. The MK1R test showed fewer false positive reactions than the VDRL test on normally inactivated sera. The VDRL test on the "overheated" sera, however, gave the same results as the MK1R test. This may be due to the thermostable factor being removed by the NaCl used in the MK1R test (3.5%) and by overheating in the variant method for the VDRL test.

Entities:  

Keywords:  CORTISONE/therapeutic use; ESTROGENS/therapeutic use; HERMAPHRODITISM/therapy; LEPROSY/complications; SYPHILIS/complications

Mesh:

Substances:

Year:  1953        PMID: 13141140      PMCID: PMC2542057     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  3 in total

1.  Clinical and serologic studies with reference to syphilis in Guatemala, Central America. III. Studies of comparative performance of the Kahn, Kolmer, Mazzini, and VDRL slide tests among leprosy patients.

Authors:  J PORTNOY; R GALVEZ; J C CUTLER
Journal:  Am J Syph Gonorrhea Vener Dis       Date:  1952-11

2.  Universal serologic reaction in pinta.

Authors:  R L KAHN; L GUTIERREZ VILLEGAS
Journal:  Am J Syph Gonorrhea Vener Dis       Date:  1952-09

3.  Behaviour and stability of serum regains in false-positive serological tests in leprosy.

Authors:  J KVITTINGEN
Journal:  Bull World Health Organ       Date:  1952       Impact factor: 9.408

  3 in total
  2 in total

1.  Serology in leprosy.

Authors:  J O de Almeida
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

2.  Serological findings in leprosy and tuberculosis with the Wassermann, Meinicke, and VDRL tests.

Authors:  H RUGE
Journal:  Bull World Health Organ       Date:  1955       Impact factor: 9.408

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.